A randomised controlled unblinded multicentre non-inferiority trial with activated vitamin D and prednisolone treatment in patients with minimal change nephropathy (ADAPTinMCN)

A randomised controlled unblinded multicentre non-inferiority trial with activated vitamin D and prednisolone treatment in patients with minimal change nephropathy (ADAPTinMCN)

Abstract Background Minimal change nephropathy (MCN) is a common cause of nephrotic syndrome in both adults and children. International guidelines recommend treatment with prednisolone 1 mg/kg/day to adults. This dose is derived from an empirically established dose in children, although children gen...

Full description

Bibliographic Details
Main Authors: Tilde Kristensen, Henrik Birn, Per Ivarsen
Format: Article
Language:English
Published: BMC 2021-07-01
Series:Trials
Subjects:
Minimal change nephropathy
Prednisolone
Activated vitamin D
Nephrotic syndrome
Adverse events
Pharmacokinetics
Online Access:https://doi.org/10.1186/s13063-021-05393-4

Internet

https://doi.org/10.1186/s13063-021-05393-4

Similar Items